BG Medicine, Inc.
US ˙ OTCPK

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Flagship Ventures Management, Inc.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Flagship Ventures Management, Inc. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SANA / Sana Biotechnology, Inc. 10% Owner 0
US:SGTX / Sigilon Therapeutics Inc 10% Owner 0
US:EVLO / Evelo Biosciences, Inc. 10% Owner 3.931.685
US:OMGA / Omega Therapeutics, Inc. 10% Owner 1.329.324
US:AXLA / Axcella Health Inc. 10% Owner 3.048.780
US:MCRB / Seres Therapeutics, Inc. 10% Owner 5.825.495
US:FHTX / Foghorn Therapeutics Inc. 10% Owner 0
US:CDAK / Codiak Biosciences Inc 10% Owner 485.949
US:KLDO / Kaleido Biosciences, Inc. 10% Owner 0
US:MRNA / Moderna, Inc. 10% Owner 0
US:BGMD / BG Medicine, Inc. 10% Owner 0
US:XLRN / Acceleron Pharma Inc 10% Owner 4.867
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Flagship Ventures Management, Inc.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BGMD / BG Medicine, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2013-01-30 BGMD AFEYAN NOUBAR 250.000 2,0000 62.500 8,0000 500.000 12 8.8 50.000 10,00
2013-01-30 BGMD AFEYAN NOUBAR 125.000 2,0000 31.250 8,0000 250.000
2013-01-30 BGMD AFEYAN NOUBAR 75.000 2,0000 18.750 8,0000 150.000
2013-01-30 BGMD AFEYAN NOUBAR 500.000 2,0000 125.000 8,0000 1.000.000
2013-01-30 BGMD AFEYAN NOUBAR 1.050.000 2,0000 262.500 8,0000 2.100.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BGMD / BG Medicine, Inc. Insider Trades
Insidersalg BGMD / BG Medicine, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-07-27 BGMD AFEYAN NOUBAR 206 2,2700 206 2,2700 468 270 0.17 -432 -92,50
2015-07-27 BGMD AFEYAN NOUBAR 16 2,2700 16 2,2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2,2700 16 2,2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2,2700 16 2,2700 36
2015-07-27 BGMD AFEYAN NOUBAR 16 2,2700 16 2,2700 36
2015-07-27 BGMD AFEYAN NOUBAR 32 2,2700 32 2,2700 73
2015-07-27 BGMD AFEYAN NOUBAR 3.390 2,2700 3.390 2,2700 7.695
2015-07-27 BGMD AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 BGMD AFEYAN NOUBAR 265 2,2700 265 2,2700 602
2015-07-27 BGMD AFEYAN NOUBAR 530 2,2700 530 2,2700 1.203
2014-12-03 BGMD AFEYAN NOUBAR 616 0,4600 154 1,8400 283
2014-12-03 BGMD AFEYAN NOUBAR 616 0,4600 154 1,8400 283
2014-12-03 BGMD AFEYAN NOUBAR 616 0,4600 154 1,8400 283
2014-12-03 BGMD AFEYAN NOUBAR 39 0,4600 10 1,8400 18
2014-12-03 BGMD AFEYAN NOUBAR 32 0,4600 8 1,8400 15
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 37 0,4600 9 1,8400 17
2014-12-03 BGMD AFEYAN NOUBAR 31 0,4600 8 1,8400 14
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 63 0,4600 16 1,8400 29
2014-12-03 BGMD AFEYAN NOUBAR 927 0,4600 232 1,8400 426
2014-12-03 BGMD AFEYAN NOUBAR 216 0,4600 54 1,8400 99
2014-12-03 BGMD AFEYAN NOUBAR 440 0,4600 110 1,8400 202
2014-12-03 BGMD AFEYAN NOUBAR 440 0,4600 110 1,8400 202
2014-12-03 BGMD AFEYAN NOUBAR 440 0,4600 110 1,8400 202
2012-08-20 BGMD AFEYAN NOUBAR 13 5,8300 3 23,3200 76
2012-08-20 BGMD AFEYAN NOUBAR 23 5,8300 6 23,3200 134
2012-08-20 BGMD AFEYAN NOUBAR 23 5,8300 6 23,3200 134
2012-08-20 BGMD AFEYAN NOUBAR 23 5,8300 6 23,3200 134
2012-05-21 BGMD AFEYAN NOUBAR 19 3,9500 5 15,8000 75
2012-05-21 BGMD AFEYAN NOUBAR 14 3,9500 4 15,8000 55
2012-05-21 BGMD AFEYAN NOUBAR 36 3,9500 9 15,8000 142
2012-05-21 BGMD AFEYAN NOUBAR 36 3,9500 9 15,8000 142
2012-05-21 BGMD AFEYAN NOUBAR 36 3,9500 9 15,8000 142

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BGMD / BG Medicine, Inc. Insider Trades
Insiderkøb EVLO / Evelo Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 1.082.251 2,3100 1.082.251 2,3100 2.500.000 35 13.3100 11.904.762 476,19
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 1.082.251 2,3100 1.082.251 2,3100 2.500.000
2023-07-11 EVLO Flagship Ventures Fund IV General Partner LLC 3.246.753 2,3100 3.246.753 2,3100 7.499.999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 4.383.561 1,4600 219.178 29,2000 6.399.999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 1.095.890 1,4600 54.794 29,2000 1.599.999
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 1.369.863 1,4600 68.493 29,2000 2.000.000
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 6.849.315 1,4600 342.466 29,2000 10.000.000
2022-05-27 EVLO Flagship Ventures Fund IV General Partner LLC 13.698.630 1,4600 684.932 29,2000 20.000.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Insidersalg EVLO / Evelo Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Insiderkøb FHTX / Foghorn Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50.000 16,0000 50.000 16,0000 800.000 52 25.88 494.000 61,75
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50.000 16,0000 50.000 16,0000 800.000
2020-10-27 FHTX Flagship Ventures Fund V General Partner LLC 50.000 16,0000 50.000 16,0000 800.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Insidersalg FHTX / Foghorn Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Insiderkøb KLDO / Kaleido Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 266.667 15,0000 266.667 15,0000 4.000.005 77 18.1 826.668 20,67
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 333.333 15,0000 333.333 15,0000 4.999.995
2019-03-04 KLDO Flagship Ventures Fund V General Partner LLC 333.333 15,0000 333.333 15,0000 4.999.995

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KLDO / Kaleido Biosciences, Inc. Insider Trades
Insidersalg KLDO / Kaleido Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KLDO / Kaleido Biosciences, Inc. Insider Trades
Insiderkøb MCRB / Seres Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-07-05 MCRB Nutritional Health LTP Fund General Partner LLC 2.912.748 3,1500 145.637 63,0000 9.175.156 119 9.0500 -7.857.141 -85,63
2022-07-05 MCRB Nutritional Health LTP Fund General Partner LLC 5.825.495 3,1500 291.275 63,0000 18.350.309

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MCRB / Seres Therapeutics, Inc. Insider Trades
Insidersalg MCRB / Seres Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MCRB / Seres Therapeutics, Inc. Insider Trades
Insiderkøb SANA / Sana Biotechnology, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMD / BG Medicine, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Insidersalg SANA / Sana Biotechnology, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMD / BG Medicine, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Flagship Ventures Management, Inc. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -70.813 0 -100,00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -2.431.281 7.293.841 -25,00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -1.181.745 0 -100,00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -345.069 1.035.208 -25,00
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -4.926.378 8.057.470 -37,94
2023-09-15 2023-09-13 4 SANA Sana Biotechnology, Inc.
Common Stock
J - Other -2.825.989 8.615.337 -24,70
2023-08-15 2023-08-11 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
U - Other -113.960 0 -100,00 14,92 -1.700.283
2023-08-15 2023-08-11 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
U - Other -683.760 0 -100,00 14,92 -10.201.699
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 3.246.753 3.931.685 474,03 2,31 7.499.999 9.082.192
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.082.251 1.493.241 263,33 2,31 2.500.000 3.449.387
2023-07-13 2023-07-11 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.082.251 1.493.241 263,33 2,31 2.500.000 3.449.387
2023-02-27 2023-02-27 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 1.329.324 1.329.324 5,78 7.683.493 7.683.493
2023-02-27 2023-02-27 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 1.993.986 7.508.693 36,16 5,78 11.525.239 43.400.246
2022-10-17 3 AXLA Axcella Health Inc.
Common Stock
3.048.780
2022-07-07 2022-07-05 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 5.825.495 5.825.495 3,15 18.350.309 18.350.309
2022-07-07 2022-07-05 4 MCRB Seres Therapeutics, Inc.
Common Stock
P - Purchase 2.912.748 5.875.711 98,31 3,15 9.175.156 18.508.490
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 13.698.630 13.698.630 1,46 20.000.000 20.000.000
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 6.849.315 8.219.791 499,78 1,46 10.000.000 12.000.895
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.369.863 5.495.324 33,21 1,46 2.000.000 8.023.173
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 1.095.890 1.887.419 138,45 1,46 1.599.999 2.755.632
2022-06-01 2022-05-27 4 EVLO Evelo Biosciences, Inc.
Common Stock
P - Purchase 4.383.561 7.590.873 136,67 1,46 6.399.999 11.082.675
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1.666.666 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -5.000.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1.666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -3.333.333 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -13.333.333 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -2.666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -3.000.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -27.388.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -22.275.232 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4.112.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 294.117 1.617.646 22,22 17,00 4.999.989 27.499.982
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1.323.529 1.323.529
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 661.764 5.514.707 13,64 17,00 11.249.988 93.750.019
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 4.852.943 4.852.943
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 970.588 970.588
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 220.588 8.617.413 2,63 17,00 3.749.996 146.496.021
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 8.396.825 8.396.825
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 5.896.386 5.896.386
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1.088.470 1.088.470
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1.666.666 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -5.000.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
C - Conversion -1.666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -3.333.333 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -13.333.333 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -2.666.667 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -3.000.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -27.388.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -22.275.232 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4.112.000 0 -100,00
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 294.117 1.617.646 22,22 17,00 4.999.989 27.499.982
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1.323.529 1.323.529
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 661.764 5.514.707 13,64 17,00 11.249.988 93.750.019
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 4.852.943 4.852.943
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 970.588 970.588
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
P - Purchase 220.588 8.617.413 2,63 17,00 3.749.996 146.496.021
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 8.396.825 8.396.825
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 5.896.386 5.896.386
2021-08-05 2021-08-03 4 OMGA Omega Therapeutics, Inc.
Common Stock
C - Conversion 1.088.470 1.088.470
2021-07-29 3 OMGA Omega Therapeutics, Inc.
Common Stock
2.197.059
2021-07-29 3 OMGA Omega Therapeutics, Inc.
Common Stock
2.197.059
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -11.585.199 0 -100,00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -11.441.326 0 -100,00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -9.725.122 0 -100,00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -1.487.371 0 -100,00
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 11.585.199 11.585.199
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 11.441.326 11.441.326
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 9.725.122 9.725.122
2021-02-10 2021-02-08 4 SANA Sana Biotechnology, Inc.
Common Stock
C - Conversion 1.487.371 1.487.371
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.481.481 0 -100,00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -370.370 0 -100,00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -4.074.074 0 -100,00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -4.444.444 0 -100,00
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
C - Conversion 1.481.481 1.481.481
2020-12-10 2020-12-08 4 SGTX Sigilon Therapeutics, Inc.
Common Stock
C - Conversion 8.888.888 8.888.888
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -43.154 0 -100,00
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -1.481.481 2.962.963 -33,33
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -1.186.310 3.258.134 -26,69
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -966.234 0 -100,00
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -642.180 1.283.282 -33,35
2020-11-25 2020-11-23 4 MCRB Seres Therapeutics, Inc.
Common Stock
J - Other -3.587.820 4.434.600 -44,72
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -3.333.333 0 -100,00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -2.666.666 0 -100,00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series B Convertible Preferred Stock
C - Conversion -1.336.293 0 -100,00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -8.333.333 0 -100,00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -7.500.000 0 -100,00
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50.000 1.851.801 2,78 16,00 800.000 29.628.816
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50.000 1.851.801 2,78 16,00 800.000 29.628.816
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 1.801.801 1.801.801
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
P - Purchase 50.000 1.491.441 3,47 16,00 800.000 23.863.056
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 1.441.441 1.441.441
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 722.320 9.280.878 8,44
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 4.504.504 8.558.558 111,11
2020-10-29 2020-10-27 4 FHTX Foghorn Therapeutics Inc.
Common Stock
C - Conversion 4.054.054 4.054.054
2020-10-13 3 CDAK Codiak BioSciences, Inc.
Common Stock
485.949
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
5.312.303
2020-07-01 3 EVLO Evelo Biosciences, Inc.
Common Stock
6.624.607
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-06-28 3 MCRB Seres Therapeutics, Inc.
Common Stock
13.333.332
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series C Preferred Stock
C - Conversion -1.251.251 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series C Preferred Stock
C - Conversion -1.251.251 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -2.570.694 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -1.928.021 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series B Preferred Stock
C - Conversion -642.674 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -1.278.720 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A-1 Preferred Stock
C - Conversion -852.480 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A Preferred Stock
C - Conversion -9.275.111 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Series A Preferred Stock
C - Conversion -3.091.704 0 -100,00
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 333.333 2.244.305 17,44 15,00 4.999.995 33.664.575
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 333.333 2.244.305 17,44 15,00 4.999.995 33.664.575
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
P - Purchase 266.667 2.560.096 11,63 15,00 4.000.005 38.401.440
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 625.625 1.910.972 48,67
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 625.625 1.910.972 48,67
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 1.285.347 1.285.347
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 964.010 5.601.565 20,79
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 321.337 2.293.429 16,29
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 639.360 639.360
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 426.240 1.972.092 27,57
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 4.637.555 4.637.555
2019-03-06 2019-03-04 4 KLDO Kaleido Biosciences, Inc.
Common Stock
C - Conversion 1.545.852 1.545.852
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2019-02-27 3 KLDO Kaleido Biosciences, Inc.
Common Stock
5.000.000
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series D Preferred Stock
C - Conversion -21.496 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series D Preferred Stock
C - Conversion -85.989 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series C Preferred Stock
C - Conversion -1.428.432 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series C Preferred Stock
C - Conversion -5.713.739 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series B Preferred Stock
C - Conversion -6.195.632 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series B Preferred Stock
C - Conversion -24.782.551 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series A Preferred Stock
C - Conversion -1.823.036 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Series A Preferred Stock
C - Conversion -7.292.145 0 -100,00
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 21.496 9.468.596 0,23
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 85.989 37.874.424 0,23
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 1.428.432 9.447.100 17,81
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 5.713.739 37.788.435 17,81
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 6.195.632 8.018.668 339,85
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 24.782.551 32.074.696 339,85
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 1.823.036 1.823.036
2018-12-13 2018-12-11 4 MRNA Moderna, Inc.
Common Stock
C - Conversion 7.292.145 7.292.145
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
22.924.794
2018-12-07 3 MRNA Moderna, Inc.
Common Stock
11.468.283
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -508 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -254 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -3.256 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -32 58.232 -0,05 2,27 -73 132.187
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 508 58.264 0,88 0,14 71 8.157
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57.756 -0,03 2,27 -36 131.106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57.756 -0,03 2,27 -36 131.106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57.756 -0,03 2,27 -36 131.106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -16 57.756 -0,03 2,27 -36 131.106
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57.772 0,44 0,14 36 8.088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57.772 0,44 0,14 36 8.088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57.772 0,44 0,14 36 8.088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 254 57.772 0,44 0,14 36 8.088
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -206 56.804 -0,36 2,27 -468 128.945
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 3.256 57.010 6,06 0,14 456 7.981
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -8.410 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4.205 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4.205 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4.205 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -4.205 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -53.857 0 -100,00
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -530 786.970 -0,07 2,27 -1.203 1.786.422
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 8.410 787.500 1,08 0,14 1.177 110.250
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779.090 -0,03 2,27 -602 1.768.534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779.090 -0,03 2,27 -602 1.768.534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779.090 -0,03 2,27 -602 1.768.534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -265 779.090 -0,03 2,27 -602 1.768.534
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4.205 779.355 0,54 0,14 589 109.110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4.205 779.355 0,54 0,14 589 109.110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4.205 779.355 0,54 0,14 589 109.110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 4.205 779.355 0,54 0,14 589 109.110
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -3.390 763.330 -0,44 2,27 -7.695 1.732.759
2015-07-29 2015-07-27 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 53.857 766.720 7,56 0,14 7.540 107.341
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 397.072 497.729 394,48 1,70 675.142 846.289
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 100.657 100.657
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 53.465 67.018 394,49 1,70 90.907 113.951
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 13.553 13.553
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
C - Conversion
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Secured Convertible Promissory Note
J - Other
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
P - Purchase 725.725 909.696 394,48 1,70 1.233.950 1.546.756
2015-07-16 2015-07-14 4 BGMD BG Medicine, Inc.
Series A Preferred Stock
C - Conversion 183.971 183.971
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 10.029 10.029
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 164.528 175.718 1.470,31
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -2.484.192 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17.080 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17.080 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -17.080 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 2.484.192 -0,02 0,46 -283 1.142.728
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 2.484.192 -0,02 0,46 -283 1.142.728
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17.080 2.484.808 0,69 0,02 342 49.696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17.080 2.484.808 0,69 0,02 342 49.696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 17.080 2.484.808 0,69 0,02 342 49.696
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -616 7.298.474 -0,01 0,46 -283 3.357.298
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -98.570 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.729 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.729 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.729 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -850 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -499 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.570 -0,06 0,46 -29 45.342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.570 -0,06 0,46 -29 45.342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.570 -0,06 0,46 -29 45.342
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.729 98.633 1,78 0,02 35 1.973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.729 98.633 1,78 0,02 35 1.973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.729 98.633 1,78 0,02 35 1.973
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -32 93.572 -0,03 0,46 -15 43.043
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 850 93.604 0,92 0,02 17 1.872
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -39 92.754 -0,04 0,46 -18 42.667
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 499 92.793 0,54 0,04 20 3.712
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -98.352 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.724 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.724 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1.724 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -847 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -464 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.352 -0,06 0,46 -29 45.242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.352 -0,06 0,46 -29 45.242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -63 98.352 -0,06 0,46 -29 45.242
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.724 98.415 1,78 0,02 34 1.968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.724 98.415 1,78 0,02 34 1.968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 1.724 98.415 1,78 0,02 34 1.968
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -31 93.369 -0,03 0,46 -14 42.950
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 847 93.400 0,92 0,02 17 1.868
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -37 92.553 -0,04 0,46 -17 42.574
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 464 92.590 0,50 0,04 19 3.704
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other 11.190 0 -100,00
2014-12-05 2014-12-04 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -703.655 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12.183 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12.183 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12.183 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -5.988 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -12.021 0 -100,00
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703.655 -0,06 0,46 -202 323.681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703.655 -0,06 0,46 -202 323.681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -440 703.655 -0,06 0,46 -202 323.681
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12.183 704.095 1,76 0,02 244 14.082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12.183 704.095 1,76 0,02 244 14.082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12.183 704.095 1,76 0,02 244 14.082
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -216 668.426 -0,03 0,46 -99 307.476
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 5.988 668.642 0,90 0,02 120 13.373
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -927 662.654 -0,14 0,46 -426 304.821
2014-12-05 2014-12-03 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 12.021 663.581 1,84 0,04 481 26.543
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
4.867
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 1.050.000 1.764.286 147,00 2,00 2.100.000 3.528.572
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 500.000 2.851.447 21,26 2,00 1.000.000 5.702.894
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 75.000 215.013 53,57 2,00 150.000 430.026
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 125.000 651.560 23,74 2,00 250.000 1.303.120
2013-02-01 2013-01-30 4 BGMD BG Medicine, Inc.
Common Stock
P - Purchase 250.000 2.434.800 11,44 2,00 500.000 4.869.600
2012-08-22 2012-08-21 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -298.137 0 -100,00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6.422 0 -100,00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6.422 0 -100,00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -6.422 0 -100,00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2.353 0 -100,00
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 298.137 -0,01 5,83 -134 1.738.139
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 298.137 -0,01 5,83 -134 1.738.139
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6.422 298.160 2,20 0,02 128 5.963
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6.422 298.160 2,20 0,02 128 5.963
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -23 285.339 -0,01 5,83 -134 1.663.526
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 6.422 285.362 2,30 0,02 128 5.707
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -13 278.940 0,00 5,83 -76 1.626.220
2012-08-22 2012-08-20 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2.353 278.953 0,85 0,03 71 8.369
2012-05-23 2012-05-23 4 BGMD BG Medicine, Inc.
Common Stock
J - Other -130.867 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7.001 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7.001 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -7.001 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2.580 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -2.497 0 -100,00
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130.867 -0,03 3,95 -142 516.925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130.867 -0,03 3,95 -142 516.925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -36 130.867 -0,03 3,95 -142 516.925
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7.001 130.903 5,65 0,02 140 2.618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7.001 130.903 5,65 0,02 140 2.618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 7.001 130.903 5,65 0,02 140 2.618
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -14 109.972 -0,01 3,95 -55 434.389
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2.580 109.986 2,40 0,02 52 2.200
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
S - Sale -19 107.406 -0,02 3,95 -75 424.254
2012-05-23 2012-05-21 4 BGMD BG Medicine, Inc.
Common Stock
X - Other 2.497 107.425 2,38 0,03 75 3.223
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)